News and reporting on breast cancer.
Theralink to Become Subsidiary of IMAC via Stock-for-Stock Reverse Merger
Theralink will become a wholly owned subsidiary of IMAC focused on proteomic testing for guiding cancer therapy and drug development.
Thermo Fisher Scientific, Pfizer Partner to Bring NGS-Based Cancer Tests to Underserved Markets
The collaboration will expand NGS-based tests for lung and breast cancers in more than 30 countries, where advanced genomic testing has been limited.
Personalis to Test MRD Assay in Triple-Negative Breast Cancer Trial With ABRCC, Criterium
The company has partnered with the Academic Breast Cancer Consortium and Criterium to assess its test in a prospective trial with five years of follow-up.
Medicare Covering Epic Sciences ctDNA Breast Cancer Panel, MDxHealth's Select MDx Test
Medicare is covering the 56-gene ctDNA panel that forms one component of the DefineMBC multiomic liquid biopsy test.
Syantra Obtains CE-IVD Mark for Breast Cancer Test
The blood-based test evaluates the expression patterns of 12 biomarkers using qPCR and machine-learning tools.
Mar 8, 2023
UK NHS Expands Access to Ibex Cancer Diagnostics
Dec 12, 2022
Oct 11, 2022